AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2022
Jun 9, 2022
33510_dirs_2022-06-09_a9c90944-abda-4fd6-97d0-5e04b6012c3d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2022-06-08
Reporting Person: Austin Mark John (VP Finance/Prin Fin&Acct Offic)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-08 | Common Stock | P | 5000 | $0.285 | Acquired | 40230 | Direct |
| 2022-06-09 | Common Stock | P | 13800 | $0.2869 | Acquired | 54030 | Direct |
More from Perspective Therapeutics, Inc.
Report Publication Announcement
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Report Publication Announcement
2026
May 11
Report Publication Announcement
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16